Position in ALXO
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$45,914
+$18,907 QoQ
Shares Held
22,900
-4.2% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#42
of 68 holders
Holding Since
Sep 2020
16 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HC Advisors, LLC holds $45,914 across 1 Biotechnology name. ALXO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALXO |
Alx Oncology Holdings Inc
This page
|
22,900 | $45,914 |
All Filings in ALXO
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,914 | 22,900 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $27,007 | 23,900 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $39,985 | 21,850 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $8,507 | 20,500 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $13,394 | 21,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,843 | 15,475 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $28,710 | 15,775 | Shares | Sole | 2024-11-05 | |
| 2022-09-30 | $133,338 | 13,933 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $114,255 | 14,123 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $233,051 | 13,790 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $386,648 | 17,992 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $606,095 | 8,206 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $479,981 | 8,778 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $659,604 | 8,945 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $845,018 | 9,803 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $245,423 | 6,503 | Shares | Sole | 2020-11-04 | |
| No filing history on record for this holder in this stock. | ||||||